GRAVINA is a cutting-edge biotech advisory firm committed to revolutionizing Diagnostics, BioTools, Health Tech, and Precision Medicine. We provide strategic consulting, product expertise, and venture capital advisory, supporting startups and established companies from R&D to market adoption. Led by Dr. Silvia Gravina, with over 15 years of experience in life sciences, GRAVINA specializes in driving product development, market expansion, and strategy. Silvia’s background includes leadership roles at Illumina, faculty positions at Albert Einstein College of Medicine, and expertise in aging/longevity research. She holds a Ph.D. in Oncology & Experimental Pathology, a Master in Pharmaceutical Biotechnology, and advanced training from Wharton in Business Strategy and Marketing.
